0001144204-15-012374.txt : 20150227 0001144204-15-012374.hdr.sgml : 20150226 20150226210027 ACCESSION NUMBER: 0001144204-15-012374 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150224 FILED AS OF DATE: 20150226 DATE AS OF CHANGE: 20150226 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: New York STATE: NY ZIP: 10011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VEITINGER KLAUS R DR CENTRAL INDEX KEY: 0001283972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 15654734 4 1 v403052_4.xml OWNERSHIP DOCUMENT X0306 4 2015-02-24 0 0001270073 INTERCEPT PHARMACEUTICALS INC ICPT 0001283972 VEITINGER KLAUS R DR C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH STREET, SUITE 505 NEW YORK NY 10011 1 0 0 0 Common Stock 2015-02-24 4 M 0 632 21.5 A 2798 D Common Stock 2015-02-24 4 S 0 632 222.50 D 2166 D Options to Purchase Common Stock 21.5 2015-02-24 4 M 0 632 0 D 2022-11-16 Common Stock 632 9536 D The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 13, 2014. All shares underlying this option have vested. /s/ Bryan Yoon, as attorney-in-fact 2015-02-26